Home  >  Products  >  UBE2V2 (ubiquitin-conjugating enzyme E2 variant 2 ) Blocking Peptide (the N terminal of UBE2V2)(100ug)
UBE2V2 (ubiquitin-conjugating enzyme E2 variant 2 ) Blocking Peptide (the N terminal of UBE2V2)(100ug)

UBE2V2 (ubiquitin-conjugating enzyme E2 variant 2 ) Blocking Peptide (the N terminal of UBE2V2)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-UBE2V2 Antibody (ARP64751_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP64751
Size: 100ug
Weight: 16kDa
Gene: 7336
Format: Lyophilized powder
Target: Ubiquitin-conjugating enzyme E2 variant proteins constitute a distinct subfamily within the E2 protein family. They have sequence similarity to other ubiquitin-conjugating enzymes but lack the conserved cysteine residue that is critical for the catalytic activity of E2s. The protein encoded by this gene also shares homology with ubiquitin-conjugating enzyme E2 variant 1 and yeast MMS2 gene product. It may be involved in the differentiation of monocytes and enterocytes.
Alternative names: DDVIT1; DDVit-1; EDAF-1; EDPF-1; EDPF1; MMS2; UEV-2; UEV2
See Full Product Listings >